Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stroke

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 162 articles:
HTML format



Single Articles


    May 2022
  1. VAN VELDHUISEN SL, Gorter TM, van Woerden G, de Boer RA, et al
    Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis.
    Eur Heart J. 2022;43:1955-1969.
    PubMed     Abstract available


  2. COLLET JP, Van Belle E, Thiele H, Berti S, et al
    Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
    Eur Heart J. 2022 May 18. pii: 6587401. doi: 10.1093.
    PubMed     Abstract available


  3. VALGIMIGLI M, Smits PC, Frigoli E, Bongiovanni D, et al
    Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention In Patients at High Bleeding Risk: a MASTER DAPT trial sub-analysis.
    Eur Heart J. 2022 May 17. pii: 6587125. doi: 10.1093.
    PubMed     Abstract available


  4. KANY S, Metzner A, Lubos E, Kirchhof P, et al
    The Atrial Fibrillation Heart Team-guiding therapy in left atrial appendage occlusion with increasingly complex patients and little evidence.
    Eur Heart J. 2022;43:1691-1692.
    PubMed    


  5. HAGEMAN SHJ, McKay AJ, Ueda P, Gunn LH, et al
    Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm.
    Eur Heart J. 2022;43:1715-1727.
    PubMed     Abstract available


    April 2022
  6. HONG S, Kim KS, Han K, Park CY, et al
    Acromegaly and cardiovascular outcomes: a cohort study.
    Eur Heart J. 2022;43:1491-1499.
    PubMed     Abstract available


    March 2022
  7. KOMEN JJ, Pottegard A, Mantel-Teeuwisse AK, Forslund T, et al
    Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.
    Eur Heart J. 2022 Mar 10. pii: 6546013. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  8. ROSSI A, Mikail N, Bengs S, Haider A, et al
    Heart-brain interactions in cardiac and brain diseases: why sex matters.
    Eur Heart J. 2022 Feb 23. pii: 6534632. doi: 10.1093.
    PubMed     Abstract available


  9. SHRAUNER W, Lord EM, Nguyen XT, Song RJ, et al
    Frailty and cardiovascular mortality in more than 3 million US Veterans.
    Eur Heart J. 2022;43:818-826.
    PubMed     Abstract available


  10. JARED BUNCH T, Steinberg BA
    Clinical strokes in atrial fibrillation: the tip of the iceberg.
    Eur Heart J. 2022 Feb 18. pii: 6532261. doi: 10.1093.
    PubMed    


  11. KUHNE M, Krisai P, Coslovsky M, Rodondi N, et al
    Silent brain infarcts impact on cognitive function in atrial fibrillation.
    Eur Heart J. 2022 Feb 17. pii: 6529516. doi: 10.1093.
    PubMed     Abstract available


  12. COSEMANS JMEM
    Platelet-derived MMP-2 in the prevention of plaque formation: how many strokes is par?
    Eur Heart J. 2022;43:515-517.
    PubMed    


  13. NURMOHAMED NS, Belo Pereira JP, Hoogeveen RM, Kroon J, et al
    Targeted proteomics improves cardiovascular risk prediction in secondary prevention.
    Eur Heart J. 2022 Feb 9. pii: 6525629. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  14. NARDUCCI ML, Volpe M
    Implantable recorders and systematic atrial fibrillation detection do not outperform standard of care in stroke prevention in the LOOP study.
    Eur Heart J. 2022;43:261-262.
    PubMed    


  15. NOUBIAP JJ
    The association of atrial fibrillation with mortality in patients with breast cancer.
    Eur Heart J. 2022 Jan 28. pii: 6516864. doi: 10.1093.
    PubMed    


  16. WEGENER S
    Triggers of stroke: anger, emotional upset, and heavy physical exertion. New insights from the INTERSTROKE study.
    Eur Heart J. 2022;43:210-212.
    PubMed    


  17. NICHOLLS M
    Preventing stroke in atrial fibrillation patients.
    Eur Heart J. 2022 Jan 25. pii: 6515302. doi: 10.1093.
    PubMed    


  18. LEHTISALO J, Rusanen M, Solomon A, Antikainen R, et al
    Effect of a multi-domain lifestyle intervention on cardiovascular risk in older people: the FINGER trial.
    Eur Heart J. 2022 Jan 20. pii: 6512207. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  19. LABORI F, Persson J, Bonander C, Jood K, et al
    Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation.
    Eur Heart J. 2021 Dec 17. pii: 6468857. doi: 10.1093.
    PubMed     Abstract available


  20. GALLI M, Benenati S, Franchi F, Rollini F, et al
    Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
    Eur Heart J. 2021 Dec 16. pii: 6464193. doi: 10.1093.
    PubMed     Abstract available


  21. KLOK FA, Ageno W, Ay C, Back M, et al
    Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on A
    Eur Heart J. 2021 Dec 7. pii: 6454843. doi: 10.1093.
    PubMed     Abstract available


  22. SMYTH A, O'Donnell M, Hankey GJ, Rangarajan S, et al
    Anger or emotional upset and heavy physical exertion as triggers of stroke: the INTERSTROKE study.
    Eur Heart J. 2021 Dec 1. pii: 6447061. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  23. GASBARRINO K, Di Iorio D, Daskalopoulou SS
    Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease.
    Eur Heart J. 2021 Nov 26. pii: 6444192. doi: 10.1093.
    PubMed     Abstract available


  24. CAMEN S, Schnabel RB
    Genetics, atrial cardiomyopathy, and stroke: enough components for a sufficient cause?
    Eur Heart J. 2021;42:4533-4535.
    PubMed    


  25. MARAZITI G, Vinson DR, Becattini C
    Echocardiography for risk stratification in patients with pulmonary embolism at low risk of death: a response.
    Eur Heart J. 2021 Nov 11. pii: 6425623. doi: 10.1093.
    PubMed    


    October 2021
  26. FEDOROWSKI A, Siller-Matula JM, Patti G
    Thrombosis and fibrinolysis in atherosclerotic cardiovascular disease: it takes two to tango.
    Eur Heart J. 2021 Oct 23. pii: 6408927. doi: 10.1093.
    PubMed    


  27. ESCANED J, Cao D, Baber U, Nicolas J, et al
    Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Eur Heart J. 2021 Oct 18. pii: 6400337. doi: 10.1093.
    PubMed     Abstract available


  28. WADSTROM BN, Wulff AB, Pedersen KM, Jensen GB, et al
    Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study.
    Eur Heart J. 2021 Oct 18. pii: 6399975. doi: 10.1093.
    PubMed     Abstract available


  29. LUSCHER TF, Davies A, Beer JH, Valgimigli M, et al
    Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum.
    Eur Heart J. 2021 Oct 8. pii: 6384672. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  30. RUSSO AM
    Alcohol intake and risk of stroke in atrial fibrillation: the lesser the better, but this is not enough.
    Eur Heart J. 2021 Sep 30. pii: 6378270. doi: 10.1093.
    PubMed    


  31. SPOSATO LA, Aspberg S, Scheitz JF, Fisher M, et al
    The World Stroke Organization Brain & Heart Task Force: collaborations between stroke physicians and cardiologists.
    Eur Heart J. 2021;42:3594-3596.
    PubMed    


  32. OYAMA K, Giugliano RP, Tang M, Bonaca MP, et al
    Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial.
    Eur Heart J. 2021 Sep 19. pii: 6372436. doi: 10.1093.
    PubMed     Abstract available


  33. LOPEZ-SENDON JL, Cyr DD, Mark DB, Bangalore S, et al
    Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial.
    Eur Heart J. 2021 Sep 13. pii: 6368943. doi: 10.1093.
    PubMed     Abstract available


  34. DEFILIPPIS AP, Trainor PJ, Thanassoulis G, Brumback LC, et al
    Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosis.
    Eur Heart J. 2021 Sep 11. pii: 6368900. doi: 10.1093.
    PubMed     Abstract available


  35. KANG EH, Park EH, Shin A, Song JS, et al
    Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout.
    Eur Heart J. 2021 Sep 11. pii: 6368678. doi: 10.1093.
    PubMed     Abstract available


  36. PETERSEN JK, Haider Butt J, Yafasova A, Torp-Pedersen C, et al
    Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.
    Eur Heart J. 2021 Sep 3. pii: 6363625. doi: 10.1093.
    PubMed     Abstract available


  37. GINSBERG HN, Packard CJ, Chapman MJ, Boren J, et al
    Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
    Eur Heart J. 2021 Sep 2. pii: 6362485. doi: 10.1093.
    PubMed     Abstract available


  38. BONNESEN MP, Frodi DM, Haugan KJ, Kronborg C, et al
    Day-to-day measurement of physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 Sep 2. pii: 6362464. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  39. WILLEMS S, Borof K, Brandes A, Breithardt G, et al
    Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.
    Eur Heart J. 2021 Aug 27. pii: 6358078. doi: 10.1093.
    PubMed     Abstract available


  40. KRANTZ MJ, Debus SE, Hsia J, Patel MR, et al
    Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
    Eur Heart J. 2021 Aug 25. pii: 6357238. doi: 10.1093.
    PubMed     Abstract available


  41. STEFANINI GG, Briguori C, Cao D, Baber U, et al
    Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
    Eur Heart J. 2021 Aug 23. pii: 6356261. doi: 10.1093.
    PubMed     Abstract available


  42. YOUNG KA, Bonnichsen CR
    Left ventricular pseudoaneurysm as source of recurrent stroke.
    Eur Heart J. 2021;42:3106.
    PubMed    


  43. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology.
    Eur Heart J. 2021 Aug 14. pii: 6352178. doi: 10.1093.
    PubMed     Abstract available


  44. BECATTINI C, Cimini LA, Agnelli G
    Home management or hospital admission for low-risk pulmonary embolism? Clinical scores versus pragmatic assessment.
    Eur Heart J. 2021 Aug 13. pii: 6350777. doi: 10.1093.
    PubMed    


  45. GAUDINO M, Di Franco A, Alexander JH, Bakaeen F, et al
    Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data.
    Eur Heart J. 2021 Aug 2. pii: 6333765. doi: 10.1093.
    PubMed     Abstract available


  46. HAN Y, Hu Y, Yu C, Guo Y, et al
    Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study.
    Eur Heart J. 2021 Aug 1. pii: 6333295. doi: 10.1093.
    PubMed     Abstract available


  47. ROMITI GF, Corica B, Pipitone E, Vitolo M, et al
    Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients.
    Eur Heart J. 2021 Aug 1. pii: 6333297. doi: 10.1093.
    PubMed     Abstract available


  48. KIM MS, Kim WJ, Khera AV, Kim JY, et al
    Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies.
    Eur Heart J. 2021 Aug 1. pii: 6333298. doi: 10.1093.
    PubMed     Abstract available


  49. REIFFEL JA
    When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease.
    Eur Heart J. 2021 Aug 1. pii: 6333293. doi: 10.1093.
    PubMed    


    July 2021
  50. KOSYAKOVSKY LB, Austin PC, Ross HJ, Wang X, et al
    Early invasive coronary angiography and acute ischaemic heart failure outcomes.
    Eur Heart J. 2021 Jul 30. pii: 6331345. doi: 10.1093.
    PubMed     Abstract available


  51. TOOROP MMA, Chen Q, Tichelaar VYIG, Cannegieter SC, et al
    Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation: a Dutch Nationwide Cohort Study.
    Eur Heart J. 2021 Jul 16. pii: 6322389. doi: 10.1093.
    PubMed     Abstract available



  52. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions.
    Eur Heart J. 2021;42:2455-2467.
    PubMed     Abstract available


    June 2021
  53. BECATTINI C, Maraziti G, Vinson DR, Ng ACC, et al
    Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis.
    Eur Heart J. 2021 Jun 28. pii: 6310284. doi: 10.1093.
    PubMed     Abstract available


  54. HE FJ, Campbell NRC, Woodward M, MacGregor GA, et al
    Salt reduction to prevent hypertension: the reasons of the controversy.
    Eur Heart J. 2021 Jun 12. pii: 6297147. doi: 10.1093.
    PubMed     Abstract available


  55. LEE SR, Choi EK, Jung JH, Han KD, et al
    Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study.
    Eur Heart J. 2021 Jun 7. pii: 6294435. doi: 10.1093.
    PubMed     Abstract available


  56. CREA F
    Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering.
    Eur Heart J. 2021;42:2137-2140.
    PubMed    


  57. TSIMIKAS S
    Elevated lipoprotein(a) and the risk of stroke in children, young adults, and the elderly.
    Eur Heart J. 2021;42:2197-2200.
    PubMed    


    May 2021
  58. KHURSHID S, Weng LC, Al-Alusi MA, Halford JL, et al
    Accelerometer-derived physical activity and risk of atrial fibrillation.
    Eur Heart J. 2021 May 25. pii: 6283622. doi: 10.1093.
    PubMed     Abstract available


  59. LANSKY AJ, Makkar R, Nazif T, Messe S, et al
    A randomized evaluation of the TriGuard HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.
    Eur Heart J. 2021 May 17. pii: 6277114. doi: 10.1093.
    PubMed     Abstract available


  60. CREA F
    New challenges in vascular biology and medicine: from unravelling the mechanisms of neointima formation to the prevention of amputations and of ischaemic stroke.
    Eur Heart J. 2021;42:1715-1719.
    PubMed    


  61. IMAZIO M, Nidorf M
    Colchicine and the heart.
    Eur Heart J. 2021 May 7. pii: 6271392. doi: 10.1093.
    PubMed     Abstract available


  62. KROHN-GRIMBERGHE M, Duerschmied D, Bode C
    What do we learn by repeating the ABC?
    Eur Heart J. 2021;42:1707-1709.
    PubMed    


    April 2021
  63. BRIEGER D, Freedman B
    Decoding stroke risk scores in atrial fibrillation: still more work to do.
    Eur Heart J. 2021 Apr 6. pii: 6213361. doi: 10.1093/eurheartj/ehaa1111.
    PubMed    


    March 2021
  64. DE JONG Y, Fu EL, van Diepen M, Trevisan M, et al
    Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function.
    Eur Heart J. 2021 Mar 26. pii: 6188994. doi: 10.1093.
    PubMed     Abstract available


  65. FIOLET ATL, Opstal TSJ, Mosterd A, Eikelboom JW, et al
    Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials.
    Eur Heart J. 2021 Mar 26. pii: 6188997. doi: 10.1093.
    PubMed     Abstract available


  66. AJJAN RA, Kietsiriroje N, Badimon L, Vilahur G, et al
    Antithrombotic therapy in diabetes: which, when, and for how long?
    Eur Heart J. 2021 Mar 25. pii: 6186730. doi: 10.1093.
    PubMed     Abstract available


  67. OYAMA K, Giugliano RP, Berg DD, Ruff CT, et al
    Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial.
    Eur Heart J. 2021 Mar 24. pii: 6184829. doi: 10.1093.
    PubMed     Abstract available


  68. ARNOLD M, Schweizer J, Nakas CT, Schutz V, et al
    Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study.
    Eur Heart J. 2021 Mar 8. pii: 6168588. doi: 10.1093.
    PubMed     Abstract available


  69. REED GW, Krishnaswamy A, Kapadia SR
    Silent brain infarction after TAVR: common but of unclear significance.
    Eur Heart J. 2021;42:1016-1018.
    PubMed    


    February 2021
  70. BUTT JH, Fosbol EL, Gerds TA, Andersson C, et al
    All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study.
    Eur Heart J. 2021 Feb 24. pii: 6149000. doi: 10.1093.
    PubMed     Abstract available


  71. WOLDENDORP K, Indja B, Bannon PG, Fanning JP, et al
    Silent brain infarcts and early cognitive outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis.
    Eur Heart J. 2021 Feb 1. pii: 6124789. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  72. SEMERANO A, Saliou G, Sanvito F, Genchi A, et al
    Fishing an anemone in the brain: embolized cardiac fibroelastoma revealed after stroke thrombectomy.
    Eur Heart J. 2021 Jan 31. pii: 6124843. doi: 10.1093.
    PubMed    


  73. PRISTIPINO C, Germonpre P, Toni D, Sievert H, et al
    European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions.
    Eur Heart J. 2021 Jan 28. pii: 6122426. doi: 10.1093/eurheartj/ehaa1070.
    PubMed     Abstract available


  74. RIENSTRA M, Van Gelder IC
    Incidence and outcome of atrial fibrillation: diversity throughout Europe.
    Eur Heart J. 2021 Jan 25. pii: 6120041. doi: 10.1093/eurheartj/ehaa1078.
    PubMed    



  75. Corrigendum to: Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascula
    Eur Heart J. 2021;42:307.
    PubMed    


  76. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment: Position Paper from the ESC Council on Stroke and the European Association for Percutaneous Cardiovascular Interventions
    Eur Heart J. 2021;42:298-307.
    PubMed     Abstract available


  77. CREA F
    Management of ischaemic stroke, prognostic impact of procedural myocardial injury, and antiplatelet treatment: the many facets of interventional cardiology.
    Eur Heart J. 2021;42:289-291.
    PubMed    


    December 2020
  78. SCHUBERT J, Lindahl B, Melhus H, Renlund H, et al
    Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Eur Heart J. 2020 Dec 24. pii: 6047259. doi: 10.1093/eurheartj/ehaa1011.
    PubMed     Abstract available


  79. PETERMANN-ROCHA F, Parra-Soto S, Gray S, Anderson J, et al
    Vegetarians, fish, poultry, and meat-eaters: who has higher risk of cardiovascular disease incidence and mortality? A prospective study from UK Biobank.
    Eur Heart J. 2020 Dec 14. pii: 6032616. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  80. NARDAI S, Lanzer P, Abelson M, Baumbach A, et al
    Interdisciplinary management of acute ischaemic stroke: Current evidence training requirements for endovascular stroke treatment.
    Eur Heart J. 2020 Nov 7. pii: 5960214. doi: 10.1093.
    PubMed     Abstract available


  81. NANJO A, Evans H, Direk K, Hayward AC, et al
    Prevalence, incidence, and outcomes across cardiovascular diseases in homeless individuals using national linked electronic health records.
    Eur Heart J. 2020;41:4011-4020.
    PubMed     Abstract available


    October 2020
  82. LIUZZO G, Patrono C
    Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial.
    Eur Heart J. 2020 Oct 17. pii: 5927543. doi: 10.1093.
    PubMed    


    September 2020
  83. WALLENTIN L, Lindback J, Eriksson N, Hijazi Z, et al
    Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
    Eur Heart J. 2020 Sep 27. pii: 5912214. doi: 10.1093.
    PubMed     Abstract available


  84. LIBBY P, Luscher T
    COVID-19 is, in the end, an endothelial disease.
    Eur Heart J. 2020;41:3038-3044.
    PubMed     Abstract available


    August 2020
  85. VRANCKX P, Valgimigli M, Eckardt L, Lewalter T, et al
    Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.
    Eur Heart J. 2020 Aug 29. pii: 5898835. doi: 10.1093.
    PubMed     Abstract available


  86. BOUABDALLAOUI N, Tardif JC, Waters DD, Pinto FJ, et al
    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
    Eur Heart J. 2020 Aug 29. pii: 5898840. doi: 10.1093.
    PubMed     Abstract available


  87. HINDRICKS G, Potpara T, Dagres N, Arbelo E, et al
    2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
    Eur Heart J. 2020 Aug 29. pii: 5899003. doi: 10.1093.
    PubMed    


  88. TUNON J, Steg PG, Bhatt DL, Bittner VA, et al
    Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
    Eur Heart J. 2020 Aug 21. pii: 5895197. doi: 10.1093.
    PubMed     Abstract available


  89. FERLINI M, Mauri S
    Variable rate of stroke after transcatheter aortic valve replacement with self-expandable valves: more doubts than certainties.
    Eur Heart J. 2020 Aug 18. pii: 5893661. doi: 10.1093.
    PubMed    


  90. THIELE H, Abdel-Wahab M, Desch S
    Stroke rates after transcatheter aortic valve replacement: does valve choice play a role?
    Eur Heart J. 2020 Aug 18. pii: 5893660. doi: 10.1093.
    PubMed    


    July 2020
  91. MENTE A, Dehghan M, Yusuf S
    Diet and health: the need for new and reliable approaches.
    Eur Heart J. 2020;41:2641-2644.
    PubMed    


    June 2020
  92. HOLT A, Gislason GH, Schou M, Zareini B, et al
    New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people.
    Eur Heart J. 2020 Jun 24. pii: 5861973. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  93. SCHMIADY MO, Sromicki J, Kucher N, Ouda A, et al
    Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation.
    Eur Heart J. 2020 May 12. pii: 5836253. doi: 10.1093.
    PubMed    


    April 2020
  94. LIAO B, Geng L, Zhang F, Shu L, et al
    Adipocyte fatty acid-binding protein exacerbates cerebral ischaemia injury by disrupting the blood-brain barrier.
    Eur Heart J. 2020 Apr 29. pii: 5827043. doi: 10.1093.
    PubMed     Abstract available


  95. BACIGALUPPI M, Martino G
    FABP4 a novel therapeutic target in ischaemic stroke.
    Eur Heart J. 2020 Apr 29. pii: 5827052. doi: 10.1093.
    PubMed    


  96. NTAIOS G, Wintermark M, Michel P
    Supracardiac atherosclerosis in embolic stroke of undetermined source: the underestimated source.
    Eur Heart J. 2020 Apr 16. pii: 5821054. doi: 10.1093.
    PubMed     Abstract available


  97. LARSSON SC, Mason AM, Back M, Klarin D, et al
    Genetic predisposition to smoking in relation to 14 cardiovascular diseases.
    Eur Heart J. 2020 Apr 16. pii: 5821049. doi: 10.1093.
    PubMed     Abstract available


  98. LINDE C
    Integrated care for atrial fibrillation: time for widespread use.
    Eur Heart J. 2020 Apr 13. pii: 5819644. doi: 10.1093.
    PubMed    


  99. HILDICK-SMITH D, Landmesser U, Camm AJ, Diener HC, et al
    Left atrial appendage occlusion with the Amplatzer Amulet device: full results of the prospective global observational study.
    Eur Heart J. 2020 Apr 3. pii: 5815608. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  100. MOUSSA O, Ardissino M, Heaton T, Tang A, et al
    Effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study.
    Eur Heart J. 2020 Mar 19. pii: 5809084. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  101. TONG TYN, Appleby PN, Key TJ, Dahm CC, et al
    The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a prospective study of 418 329 participants in the EPIC cohort across nine European countries.
    Eur Heart J. 2020 Feb 24. pii: 5748325. doi: 10.1093.
    PubMed     Abstract available


  102. GARNVIK LE, Malmo V, Janszky I, Ellekjaer H, et al
    Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study.
    Eur Heart J. 2020 Feb 11. pii: 5733768. doi: 10.1093.
    PubMed     Abstract available


  103. HUANG HK, Liu PP, Hsu JY, Lin SM, et al
    Fracture risks among patients with atrial fibrillation receiving different oral anticoagulants: a real-world nationwide cohort study.
    Eur Heart J. 2020 Feb 1. pii: 5718429. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  104. MALMBORG M, Schmiegelow MDS, Norgaard CH, Munch A, et al
    Does type 2 diabetes confer higher relative rates of cardiovascular events in women compared with men?
    Eur Heart J. 2019 Dec 20. pii: 5682397. doi: 10.1093.
    PubMed     Abstract available


  105. GUNDLUND A, Olesen JB, Butt JH, Christensen MA, et al
    One-year outcomes in atrial fibrillation presenting during infections: a nationwide registry-based study.
    Eur Heart J. 2019 Dec 17. pii: 5680017. doi: 10.1093.
    PubMed     Abstract available


  106. JONES NR, Taylor CJ, Hobbs FDR, Bowman L, et al
    Screening for atrial fibrillation: a call for evidence.
    Eur Heart J. 2019 Dec 7. pii: 5663566. doi: 10.1093.
    PubMed     Abstract available


  107. BHARADWAJ A, Potts J, Mohamed MO, Parwani P, et al
    Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
    Eur Heart J. 2019 Dec 4. pii: 5652220. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  108. LUSCHER TF
    Optimizing heart failure management: anticoagulation, diuretic withdrawal, iron substitution, and novel inotropes.
    Eur Heart J. 2019;40:3579-3582.
    PubMed    


  109. SINNAEVE PR, Schwartz GG, Wojdyla DM, Alings M, et al
    Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.
    Eur Heart J. 2019 Nov 16. pii: 5626150. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  110. GARGIULO G, Goette A, Tijssen J, Eckardt L, et al
    Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based rand
    Eur Heart J. 2019 Oct 25. pii: 5607287. doi: 10.1093.
    PubMed     Abstract available


  111. IBANEZ B
    And fibrinolysis became pharmacoinvasive.
    Eur Heart J. 2019 Oct 12. pii: 5586502. doi: 10.1093.
    PubMed    


  112. LIBERALE L, Gaul DS, Akhmedov A, Bonetti NR, et al
    Endothelial SIRT6 blunts stroke size and neurological deficit by preserving blood-brain barrier integrity: a translational study.
    Eur Heart J. 2019 Oct 11. pii: 5585651. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  113. WIJTVLIET EPJP, Tieleman RG, van Gelder IC, Pluymaekers NAHA, et al
    Nurse-led vs. usual-care for atrial fibrillation.
    Eur Heart J. 2019 Sep 23. pii: 5572602. doi: 10.1093.
    PubMed     Abstract available


  114. GUHA A, Dey AK, Jneid H, Ibarz JP, et al
    Atrial Fibrillation in the Era of Emerging Cancer Therapies.
    Eur Heart J. 2019;40:3007-3010.
    PubMed    


  115. SULZGRUBER P, Wassmann S, Semb AG, Doehner W, et al
    Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
    Eur Heart J. 2019;40:3010-3012.
    PubMed    


  116. POTPARA T, Steffel J
    Strategies in patients with atrial fibrillation taking non-vitamin K antagonist oral anticoagulants (NOACs) and co-medications with possible drug-drug interaction.
    Eur Heart J. 2019 Sep 20. pii: 5572224. doi: 10.1093.
    PubMed    


    August 2019
  117. SERRUYS PW, Takahashi K, Chichareon P, Kogame N, et al
    Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.
    Eur Heart J. 2019;40:2595-2604.
    PubMed     Abstract available


  118. MAGGIONI AP, Andreotti F
    Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?
    Eur Heart J. 2019 Aug 1. pii: 5542639. doi: 10.1093.
    PubMed    


    July 2019
  119. KUHNE M, Krisai P, Conen D, Osswald S, et al
    The heart-brain connection: further establishing the relationship between atrial fibrillation and dementia?
    Eur Heart J. 2019;40:2324-2326.
    PubMed    


  120. KILLU AM, Gersh BJ
    Response to: Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management.
    Eur Heart J. 2019 Jul 13. pii: 5532107. doi: 10.1093.
    PubMed    


  121. LI HF, Liang B, Li HY
    Risk stratification for stroke in atrial fibrillation: incorporating neurologists in the comprehensive management.
    Eur Heart J. 2019 Jul 13. pii: 5532108. doi: 10.1093.
    PubMed    


    June 2019
  122. KOTECHA D, Castella M
    Is it time to treat post-operative atrial fibrillation just like regular atrial fibrillation?
    Eur Heart J. 2019 Jun 25. pii: 5523037. doi: 10.1093.
    PubMed    


  123. CONEN D, Alonso-Coello P, Douketis J, Chan MTV, et al
    Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery.
    Eur Heart J. 2019 Jun 25. pii: 5523034. doi: 10.1093.
    PubMed     Abstract available


  124. PIAZZA G, Hurwitz S, Galvin CE, Harrigan L, et al
    Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
    Eur Heart J. 2019 Jun 22. pii: 5521151. doi: 10.1093.
    PubMed     Abstract available


  125. KIM D, Yang PS, Yu HT, Kim TH, et al
    Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort.
    Eur Heart J. 2019 Jun 18. pii: 5520105. doi: 10.1093.
    PubMed     Abstract available


    May 2019
  126. FRIBERG L, Andersson T, Rosenqvist M
    Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation.
    Eur Heart J. 2019 May 16. pii: 5490291. doi: 10.1093.
    PubMed     Abstract available


    April 2019
  127. HOHNLOSER SH, Camm J, Cappato R, Diener HC, et al
    Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
    Eur Heart J. 2019 Apr 11. pii: 5446017. doi: 10.1093.
    PubMed     Abstract available


  128. BONDE AN, Blanche P, Staerk L, Gerds TA, et al
    Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study.
    Eur Heart J. 2019 Apr 1. pii: 5424120. doi: 10.1093.
    PubMed     Abstract available


    March 2019
  129. NOSEWORTHY PA, Gersh BJ, Kent DM, Piccini JP, et al
    Atrial fibrillation ablation in practice: assessing CABANA generalizability.
    Eur Heart J. 2019 Mar 15. pii: 5381200. doi: 10.1093.
    PubMed     Abstract available


    February 2019
  130. OLDGREN J, Steg PG, Hohnloser SH, Lip GYH, et al
    Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial.
    Eur Heart J. 2019 Feb 21. pii: 5359476. doi: 10.1093.
    PubMed     Abstract available


    January 2019
  131. GOLDHABER SZ, Piazza G
    Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities.
    Eur Heart J. 2019 Jan 25. pii: 5301477. doi: 10.1093.
    PubMed    


  132. KHAN AA, Lip GYH
    Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
    Eur Heart J. 2019 Jan 21. pii: 5298544. doi: 10.1093.
    PubMed    


    December 2018
  133. ASAMI M, Windecker S, Praz F, Lanz J, et al
    Transcatheter aortic valve replacement in patients with concomitant mitral stenosis.
    Eur Heart J. 2018 Dec 28. pii: 5265291. doi: 10.1093.
    PubMed     Abstract available


  134. YU HT, Shim J, Park J, Kim TH, et al
    When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation? A multicentre prospective randomized study.
    Eur Heart J. 2018 Dec 27. pii: 5263768. doi: 10.1093.
    PubMed     Abstract available


  135. VLASTRA W, Chandrasekhar J, Munoz-Garcia AJ, Tchetche D, et al
    Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration.
    Eur Heart J. 2018 Dec 24. pii: 5259360. doi: 10.1093.
    PubMed     Abstract available


  136. SEEGER J, Kapadia SR, Kodali S, Linke A, et al
    Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Eur Heart J. 2018 Dec 24. pii: 5259357. doi: 10.1093.
    PubMed     Abstract available


  137. WANG KL, Lopes RD, Patel MR, Buller HR, et al
    Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials.
    Eur Heart J. 2018 Dec 22. pii: 5255630. doi: 10.1093.
    PubMed     Abstract available


  138. KILLU AM, Granger CB, Gersh BJ
    Risk stratification for stroke in atrial fibrillation: a critique.
    Eur Heart J. 2018 Dec 1. pii: 5224504. doi: 10.1093.
    PubMed     Abstract available


    November 2018
  139. STEFFEL J, Potpara TS
    Challenges in clinical decision-making on concomitant drug therapies in patients with atrial fibrillation taking oral anticoagulants.
    Eur Heart J. 2018 Nov 29. pii: 5219661. doi: 10.1093.
    PubMed    


    October 2018
  140. YOON SH, Whisenant BK, Bleiziffer S, Delgado V, et al
    Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.
    Eur Heart J. 2018 Oct 23. pii: 5143983. doi: 10.1093.
    PubMed     Abstract available


    September 2018
  141. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014.
    Eur Heart J. 2018 Sep 19. pii: 5103432. doi: 10.1093.
    PubMed     Abstract available


  142. FUJIMOTO D, Mochizuki Y, Nakagiri K, Shite J, et al
    Unusual rapid progression of non-bacterial thrombotic endocarditis in a patient with bladder cancer despite undergoing intensification treatment with rivaroxaban for acute venous thromboembolism.
    Eur Heart J. 2018 Sep 9. pii: 5093360. doi: 10.1093.
    PubMed    


    August 2018
  143. FREEDMAN B
    Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention?
    Eur Heart J. 2018 Aug 10. pii: 5070412. doi: 10.1093.
    PubMed    


  144. SHEHATA N, Mistry N, da Costa BR, Pereira TV, et al
    Restrictive compared with liberal red cell transfusion strategies in cardiac surgery: a meta-analysis.
    Eur Heart J. 2018 Aug 10. pii: 5070413. doi: 10.1093.
    PubMed     Abstract available


    July 2018
  145. COWAN JC, Wu J, Hall M, Orlowski A, et al
    A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.
    Eur Heart J. 2018 Jul 5. pii: 5049393. doi: 10.1093.
    PubMed     Abstract available


    June 2018
  146. SIBBING D, Gross L, Trenk D, Jacobshagen C, et al
    Age and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: results from the randomized TROPICAL-ACS trial.
    Eur Heart J. 2018 Jun 14. pii: 5037998. doi: 10.1093.
    PubMed     Abstract available


    May 2018
  147. JANSSENS SP, Bogaert J, Zalewski J, Toth A, et al
    Nitric oxide for inhalation in ST-elevation myocardial infarction (NOMI): a multicentre, double-blind, randomized controlled trial.
    Eur Heart J. 2018 May 24. pii: 5003325. doi: 10.1093.
    PubMed     Abstract available


  148. FRIEDMAN DJ, Granger CB
    Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?
    Eur Heart J. 2018 May 19. pii: 4999868. doi: 10.1093.
    PubMed    


    April 2018
  149. FANAROFF AC, Steffel J, Alexander JH, Lip GYH, et al
    Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universe.
    Eur Heart J. 2018 Apr 23. pii: 4982606. doi: 10.1093.
    PubMed     Abstract available


  150. EZEKOWITZ MD, Pollack CV Jr, Halperin JL, England RD, et al
    Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
    Eur Heart J. 2018 Apr 6. pii: 4963487. doi: 10.1093.
    PubMed     Abstract available


    March 2018
  151. KIRCHHOF P, Haeusler KG, Blank B, De Bono J, et al
    Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.
    Eur Heart J. 2018 Mar 20. pii: 4943979. doi: 10.1093.
    PubMed     Abstract available


  152. STEFFEL J, Verhamme P, Potpara TS, Albaladejo P, et al
    The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
    Eur Heart J. 2018 Mar 17. pii: 4942493. doi: 10.1093.
    PubMed     Abstract available


  153. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Abstract available


    January 2018
  154. MEHLUM MH, Liestol K, Kjeldsen SE, Julius S, et al
    Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks.
    Eur Heart J. 2018 Jan 20. pii: 4815726. doi: 10.1093.
    PubMed     Abstract available


  155. MAHAJAN R, Perera T, Elliott AD, Twomey DJ, et al
    Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis.
    Eur Heart J. 2018 Jan 10. pii: 4797540. doi: 10.1093.
    PubMed     Abstract available


  156. HEALEY JS
    The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation.
    Eur Heart J. 2018 Jan 9. pii: 4796907. doi: 10.1093.
    PubMed    


  157. LIP GYH, Lane DA, Potpara TS
    Innovative strategies to improve adherence to non-vitamin K antagonist oral anticoagulants for stroke prevention in atrial fibrillation.
    Eur Heart J. 2018 Jan 6. pii: 4791955. doi: 10.1093.
    PubMed    


  158. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    PubMed     Abstract available


  159. DESTEGHE L, Vijgen J, Koopman P, Dilling-Boer D, et al
    Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation.
    Eur Heart J. 2018 Jan 2. pii: 4782504. doi: 10.1093.
    PubMed     Abstract available


    December 2017
  160. POKORNEY SD, Granger CB
    Traumatic injury: another unjustified reason to stop oral anticoagulation for atrial fibrillation.
    Eur Heart J. 2017 Dec 13. pii: 4735276. doi: 10.1093.
    PubMed    


    November 2017
  161. SPOSATO LA, Lopes RD
    Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation?
    Eur Heart J. 2017 Nov 27. pii: 4665696. doi: 10.1093.
    PubMed    


    October 2017
  162. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: